Armata Pharmaceuticals (ARMP) Intangibles (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Intangibles data on file, last reported at $10.3 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles changed 0.0% year-over-year to $10.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.3 million (changed 0.0% YoY), and the FY2025 full-year result was $10.3 million, changed 0.0% from the prior year.
• Intangibles steadied at $10.3 million in Q1 2026, from $10.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $10.3 million in Q1 2022 to a low of $10.3 million in Q1 2022.
• A 5-year average of $10.3 million and a median of $10.3 million in 2022 frame the typical range for Intangibles.
• Peak annual rise in Intangibles reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Tracing ARMP's Intangibles over 5 years: stood at $10.3 million in 2022, then changed by 0.0% to $10.3 million in 2023, then changed by 0.0% to $10.3 million in 2024, then changed by 0.0% to $10.3 million in 2025, then changed by 0.0% to $10.3 million in 2026.
• Business Quant data shows ARMP's Intangibles at $10.3 million in Q1 2026, $10.3 million in Q4 2025, and $10.3 million in Q3 2025.